Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Hikma Pharmaceuticals (GB:HIK) has released an update. Hikma Pharmaceuticals has decided to reappoint PricewaterhouseCoopers LLP as its external auditor starting in 2026, following a competitive ...

Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...

Hikma Pharmaceuticals PLC HIK shares advanced 1.67% to £18.31 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0.84% to ...

This market presents significant opportunities for companies to innovate by developing new treatment protocols ... Companies like Aprecia Pharmaceuticals Co, Austedo, Hikma Pharmaceuticals ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma ... business and are pleased to announce the signing of a significant new long-term contract with a global pharmaceutical company. Subject to ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Out-of-home posters using the term “HER2.0” showed that the drug could also be used to fight gastrointestinal cancers.

He steps into the new roles without any additional compensation and without an employment agreement specific to these roles. Titan Pharmaceuticals has initiated a search for a full-time chief ...